- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-tetramer
- Ligands
- 13 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x DXE: 1,2-DIMETHOXYETHANE(Non-covalent)
- 1 x M2M: 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE(Non-covalent)
- 3 x B3P: 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
B3P.7: 12 residues within 4Å:- Chain A: Y.24, F.25, E.118, E.141, R.142, M.143, E.145, S.146, E.239, H.243, Q.321
- Ligands: 6L7.8
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:S.146, A:E.239, A:E.239, A:E.239, A:H.243
- Water bridges: A:S.146
B3P.14: 12 residues within 4Å:- Chain B: A.21, Y.24, F.25, E.118, E.141, R.142, M.143, E.145, S.146, E.239, Q.321
- Ligands: 6L7.15
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:E.141, B:R.142, B:E.145, B:S.146, B:E.239, B:E.239
- Water bridges: B:E.118, B:E.118, B:S.146, B:S.146
B3P.24: 13 residues within 4Å:- Chain D: A.21, Y.24, F.25, E.118, E.141, R.142, M.143, E.145, S.146, E.239, H.243, Q.321
- Ligands: 6L7.25
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:E.145
- Hydrogen bonds: D:Y.24, D:R.142, D:R.142, D:E.145, D:E.145, D:E.239, D:H.243
- Water bridges: D:E.118, D:E.118, D:Q.321, D:Q.321
- 4 x 6L7: [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-azaniumylethyl)-[(3~{S})-3-azaniumyl-4-oxidanyl-4-oxidanylidene-butyl]azanium(Non-covalent)
6L7.8: 29 residues within 4Å:- Chain A: Y.24, F.25, Y.28, Q.34, M.37, M.38, R.43, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, E.141, M.143, S.146
- Ligands: B3P.7
19 PLIP interactions:19 interactions with chain A- Hydrogen bonds: A:Y.24, A:Y.28, A:Q.34, A:Q.34, A:G.67, A:E.89, A:E.89, A:A.90, A:S.91, A:V.117, A:E.118, A:E.132
- Water bridges: A:Y.28, A:W.290
- Salt bridges: A:R.43, A:E.132
- pi-Stacking: A:F.25, A:F.25
- pi-Cation interactions: A:Y.28
6L7.15: 28 residues within 4Å:- Chain B: Y.24, F.25, Y.28, Q.34, M.37, R.43, D.65, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, M.134, E.141, M.143, S.146
- Ligands: B3P.14
17 PLIP interactions:17 interactions with chain B- Hydrogen bonds: B:Y.28, B:Q.34, B:Q.34, B:G.67, B:E.89, B:E.89, B:A.90, B:S.91, B:V.117, B:E.118, B:E.132
- Water bridges: B:Y.28
- Salt bridges: B:R.43, B:E.132
- pi-Stacking: B:F.25, B:F.25
- pi-Cation interactions: B:Y.28
6L7.21: 30 residues within 4Å:- Chain C: Y.24, F.25, Y.28, Q.34, M.37, R.43, D.65, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, E.141, M.143, S.146, W.290
- Ligands: EDO.19
15 PLIP interactions:15 interactions with chain C- Hydrogen bonds: C:Y.28, C:Q.34, C:Q.34, C:G.67, C:G.69, C:E.89, C:E.89, C:A.90, C:S.91, C:V.117, C:E.118, C:E.132
- Salt bridges: C:R.43, C:E.132
- pi-Stacking: C:F.25
6L7.25: 29 residues within 4Å:- Chain D: Y.24, F.25, Y.28, Q.34, M.37, M.38, R.43, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, E.141, M.143, S.146
- Ligands: B3P.24
19 PLIP interactions:19 interactions with chain D- Hydrogen bonds: D:Y.24, D:Y.28, D:Q.34, D:G.67, D:S.70, D:E.89, D:E.89, D:A.90, D:S.91, D:V.117, D:E.118, D:E.132
- Water bridges: D:Y.28, D:G.71
- Salt bridges: D:R.43, D:E.132
- pi-Stacking: D:F.25, D:F.25
- pi-Cation interactions: D:Y.28
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cura, V. et al., Crystal structure of mouse CARM1 in complex with inhibitor SA0678. To Be Published
- Release Date
- 2018-05-30
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-tetramer
- Ligands
- 13 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x DXE: 1,2-DIMETHOXYETHANE(Non-covalent)
- 1 x M2M: 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE(Non-covalent)
- 3 x B3P: 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
- 4 x 6L7: [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-azaniumylethyl)-[(3~{S})-3-azaniumyl-4-oxidanyl-4-oxidanylidene-butyl]azanium(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cura, V. et al., Crystal structure of mouse CARM1 in complex with inhibitor SA0678. To Be Published
- Release Date
- 2018-05-30
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D